STEPHEN P. SQUINTO - 18 Feb 2022 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Director
Signature
/s/ Vered Bisker-Leib, attorney-in-fact
Issuer symbol
CMPX
Transactions as of
18 Feb 2022
Net transactions value
$0
Form type
4
Filing time
23 Feb 2022, 16:45:18 UTC
Previous filing
21 May 2021
Next filing
20 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 18 Feb 2022 Common Stock 30,000 $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in substantially equal monthly installments over four years.

Remarks:

Exhibit 24 - Power of Attorney